Lotilaner: Difference between revisions
Content deleted Content added
{{Insecticides}} |
more ids |
||
| Line 45: | Line 45: | ||
| DrugBank = |
| DrugBank = |
||
| UNII = HEH4938D7K |
| UNII = HEH4938D7K |
||
| ChemSpiderID = 32699771 |
|||
| ChEMBL = 3707310 |
|||
| KEGG = D11212 |
|||
<!-- Chemical and physical data --> |
<!-- Chemical and physical data --> |
||
| C=20 | H=14 | Cl=3 | F=6 | N=3 | O=3 | S=1 |
| C=20 | H=14 | Cl=3 | F=6 | N=3 | O=3 | S=1 |
||
Revision as of 00:30, 2 December 2019
 | |
| Clinical data | |
|---|---|
| Trade names | Credelio |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H14Cl3F6N3O3S |
| Molar mass | 596.75 g·mol−1 |
| 3D model (JSmol) | |
| |
Lotilaner (INN; trade name Credelio) is a veterinary drug used to control fleas and ticks in dogs.[1] It is indicated for for the treatment and prevention of flea infestations (Ctenocephalides felis) and for the treatment and control of tick infestations including lone star tick (Amblyomma americanum), American dog tick (Dermacentor variabilis), black-legged tick (Ixodes scapularis), and brown dog tick (Rhipicephalus sanguineus).[2]
References
- ^ Kuntz, Emmanuelle A.; Kammanadiminti, Srinivas (2017). "Safety evaluation of lotilaner in dogs after oral administration as flavoured chewable tablets (Credelio™)". Parasites & Vectors. 10. doi:10.1186/s13071-017-2468-y.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ "FREEDOM OF INFORMATION SUMMARY, SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION, NADA 141-494, Credelio, Lotilaner, Chewable Tablets, Dogs". September 3, 2019.
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |